Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death

Journal of Immunology

Volumn 180, Issue 12, 2008, Pages 8316-8326

  Reardon, Colin ^a   Wang, Arthur ^a   McKay, Derek M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROBENZENE SULFONIC ACID; FAS ANTIGEN; FAS LIGAND; SMAD7 PROTEIN; SULFONIC ACID DERIVATIVE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; 1 FLUORO 2,4 DINITROBENZENE; 2,4 DINITROFLUOROBENZENE SULFONIC ACID; 2,4-DINITROFLUOROBENZENE SULFONIC ACID; DRUG DERIVATIVE; FAS PROTEIN, MOUSE; FASL PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; HAPTEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; HISTOPATHOLOGY; ILEUM; IN VITRO STUDY; LYMPHOCYTE DEPLETION; LYMPHOCYTE HOMING; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; LYMPHOCYTOPENIA; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; TIME;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; COLITIS; DINITROFLUOROBENZENE; FAS LIGAND PROTEIN; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HAPTENS; INTESTINAL MUCOSA; LYMPHOPENIA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 50949085390     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.12.8316     Document Type: Article

References (51)

1. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
2. Stappenbeck, T. S., L. V. Hooper, and J. I. Gordon. 2002. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci USA 99: 15451-15455.
3. Rhee, K. J., P. Sethupathi, A. Driks, D. K. Lanning, and K. L. Knight. 2004. Role of commensal bacteria in development of gut-associated lymphoid tissues and pre-immune antibody repertoire. J. Immunol. 172: 1118-1124.
4. + regulatory T cells. Nat. Immunol. 4: 330-336.
5. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
6. + regulatory T cells in human thymus. Nature 436: 1181-1185.
7. -T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172: 5149-5153.
8. + regulatory T cells impaired for intestinal homing can prevent colitis. J. Immunol. 174: 7487-7491.
9. + regulatory T cells responsible for protection against diabetes. Proc. Nail. Acad. Sci. USA 101: 4572-4577.
10. + Tcells during cure of colitis. J. Immunol. 177: 5852-5860.
11. Hunter, M. M., A. Wang, C. L. Hirota, and D. M. McKay. 2005. Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically-induced colitis. J. Immunol. 174: 7368-7375.
12. Lefrancois, L., and N. Lycke. 2003. Basic protocol 3: isolation of lymphocytes from intestinal LP. In Current Protocols in Immunology. John Wiley & Sons, Inc., Hoboken, NJ, pp. 3.19.6-3.19.15.
13. + T cells. J. Immunol. 162: 5592-5600.
14. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169: 2461-2465.
15. Reardon, G. and D. M. McKay. 2007. TGF-0 suppresses IFN-γ-STATl- depen-dent gene transcription by enhancing STATI-PIAS1 interactions in epithelia but not monocytes/macrophages. J. Immunol. 178: 4284-4295.
16. Poccia, F., B. Cipriani, S. Vendetti, V. Colizzi, Y. Poquet, L. Battistini, M. Lopez-Botet, J.-J. Foumie, and M.-L. Cougeonn. 1997. CD94/NKC2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vy9VS2 T lymphocytes. J. Immunol. 159: 6009-6017.
17. + regulatory T cells. J. Exp. Med. 201: 1061-1067.
18. + regulatory T cells are highly susceptible to CD95 Iigand-but not to TCR-mediated cell death. J. Immunol. 175: 32-36.
19. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunily and lymphoproliferative disease. Annu. Rev. Immunol. 9: 243-269.
20. Schubert, L. A., E. Jeffery, Y. Zhang, F. Ramsdell, and S. F. Ziegler. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276: 37672-37679.
21. Kim, J. M., J. P. Rasmussen, and A. Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8: 191-197.
22. + regulatory T cells suppress Thl mediated experimental colitis. Gut 55: 671-680.
23. Nadkami, S., C. Mauri, and M. R. Ehrenstein. 2007. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β. J. Exp. Med. 204: 33-39.
24. Williams, L. M., and A. Y. Rudensky. 2007. Maintenance of the Foxp3-depcn-dent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8: 277-284.
25. Sanovic, S., D. P. Lamb, and M. G. Blennerhassett. 1999. Damage to the enteric nervous system in experimental colitis. Am. J. Pathol. 155: 1051-1057.
26. + T regulatory cells. J. Immunol. 179: 154-161.
27. + T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 131: 525-537.
28. high regulatory T cells in Helicobacter pylori-infected patients. Infect. Immun. 73: 523-531.
29. + natural regulatory T cells are specific for microbial antigens. J. Exp. Med. 203: 777-788.
30. + T(R) cells suppress innate immune pathology through cy-tokine-dependent mechanisms. J. Exp. Med. 197: 111-119.
31. De Lucai A., C. Montagnoli, T. Zelante, P. Bonifazi, S. Bozza, S. Moretti, C. D'Angelo, C. Vacca, L. Boon, F. Bistoni, et al. 2007. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J. Immunol. 179: 5999-6008.
32. Khan, W. I., P. A. Blennerhasset, A. K. Varghese, S. K. Chowdhury, P. Omsted, Y. Deng, and S. M. Collins. 2002. Intestinal nematode infection ameliorates experimental colitis in mice. Infect. Immun. 70: 5931-5937.
33. Ulloa, L., J. Doody, and J. Massague. 1999. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature 397: 710-713.
34. 1 signaling in chronic inflammatory bowel disease. J. Clin. Invest. 108: 601-609.
35. Babyatsky, M. W., G. Rossiter, and D. K. Podolsky. 1996. Expression of transforming growth factors α and β in colonic mucosa in inflammatory bowel disease. Gastroenterology 110: 975-984.
36. Monteleone, G., F. Pallone, and T. T. MacDonald. 2004. Smad7 in TGF-β-me-diated negative regulation of gut inflammation. Trends Immunol. 25: 513-517.
37. Boirivant, M., F. Pallone, C. Di Giacinto, D. Fina, I. Monteleone, M. Marinaro, R. Caruso, A. Colantoni, G. Palmieri, M. Sanchez, et al. 2006. Inhibition of Smad7 with a specific anlisense oligonucleotide facilitates TGF-β,-mediated suppression of colitis. Gastroenterology 131: 1786-1798.
38. Beck, P. L., I. M. Rosenberg, R. J. Xavier, T. Koh, J. F. Wong, and D. K. Podolsky. 2003. Transforming growth factor-β mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells. Am. J. Pathol. 162: 597-608.
39. + regulatory T cells in the periphery. Castroenterology 126: 1759-1770.
40. + TR cells. Int. Immunol. 18: 1265-1277.
41. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448.
42. Zhang, II. O., M. Fleck, E. R. Kem, D. Liu, Y. Wang, II. C. Hsu, P. Yang, Z. Wang, D. T. Curiel, T. Zhou, and J. D. Mountz. 2000. Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas li-gand-deficient mice. J. Clin. Invest. 105: 813-821.
43. Lin, T., T. Brunner, B. Tietz, J. Madsen, E. Bonfoco, M. Reaves, M. Huflejt, and D. R. Green. 1998. Fas ligand-mediated killing by intestinal intraepithelial lymphocytes: participation in intestinal graft-versus-host disease. J. Clin. Invest. 101: 570-577.
44. Sayani, F. A., C. M. Keenan, M. D. Van Sickle, K. R. Amundson, E. J. Parr, R. D. Mathison, W. K. MacNaughton, J. E. Braun, and K. A. Sharkey. 2004. The expression and role of Fas ligand in intestinal inflammation. Neurogastroenterol. Motil. 16: 61-74.
45. + T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 31: 1122-1131.
46. + regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 116: 2423-2433.
47. Seino, K. I., K. Iwabuchi, N. Kayagaki, R. Miyata, I. Nagaoka, A. Matsuzawa, K. Fukao, H. Yagita, and K. Okumura. 1998. Cutting edge: chemotactic activity of soluble Fas ligand against phagocytes. J. Immunol. 161: 4484-4488.
48. Ottonello, L., G. Tortolina, M. Amelotti, and F. Dallegri. 1999. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. J. Immunol. 162: 3601-3606.
49. Bettelli, E., Y. Carrier, W. Gao, T. Kom, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
50. -T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J. Immunol. 178: 6725-6729.
51. Atreya, R., J. Mudter, S. Finotto, J. Mullberg, T. Jostock, S. Wirtz, M. Schutz, B. Bartsch, M. Holtmann, C. Becker, et al. 2000. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn's disease and experimental colitis in vivo. Nat. Med. 6: 583-588.